Related Experiment Video
Updated: Jul 6, 2025

09:28
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
11.6K
Non-mutational neoantigens in disease
Lawrence J Stern1,2, Cristina Clement3, Lorenzo Galluzzi4,5,6
1Department of Pathology, UMass Chan Medical School, Worcester, MA, USA.
Nature Immunology
|January 3, 2024
Summary
Mature T cells can recognize novel antigens not just from mutations, but also from non-mutational processes. This discovery expands our understanding of adaptive immunity and immunological memory formation.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Adaptive immunity relies on T cells recognizing peptides presented by MHC molecules.
- T cell recognition is traditionally thought to focus on mutated or foreign antigens.
- Emerging evidence suggests non-mutational mechanisms also generate T cell-recognized antigens.
Purpose of the Study:
- To review mechanisms generating non-mutational neoantigens.
- To discuss the implications of non-mutational neoantigen recognition in human disease.
Main Methods:
- Literature review of preclinical and clinical data.
- Analysis of various molecular and cellular processes.
Main Results:
- Non-mutational neoantigens arise from epitope mimicry, cryptic epitopes, non-canonical translation, RNA splicing, ribosomal processing errors, and post-translational modifications.
- These neoantigens are efficiently recognized by mature T cells.
Conclusions:
- The repertoire of antigens recognized by T cells is broader than previously assumed.
- Non-mutational neoantigens play a significant role in immune responses and human diseases.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Antigens Involved in Adaptive Immunity
498
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
498
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Mutations
82.5K
Overview
82.5K

